Application

18531914 · COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING STARGARDT'S DISEASE AND/OR RETINAL BINDING PROTEIN 4 (RBP4)-ASSOCIATED DISORDERS

Filed 2023-12-07 · Pending The official file ↗ · Art unit 1636 · Examiner Qiwen Nmn Su-Tobon Typical · CPC C12N 15/113 · Alnylam Pharmaceuticals, Inc. · MCCARTER & ENGLISH, LLP / ALNYLAM PHARMACEUTICALS

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

31.6 mo

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.